2012Journal of Tongji UniversityRequires access

Liver fat contents in type 2 diabetic patients with nonalcoholic fatty liver disease under metformin treatment

WU Guo-ting

Open publisher page 0 citations

Abstract

Objective To investigate the change of liver fat contents in type 2 diabetic patients with non-alcoholic fatty liver disease(NAFLD) under metformin treatment.Methods Fifty patients with type 2 diabetes mellitus(T2DM) and NAFLD were assigned to receive metformin treatment(groupA,n=25) or non-metformin treatment(group B,n=25).The intrahepatic fat contents were examined by MRS;the mass of fat peak/the mass of fat peak + the mass of water peak 5.5% was diagnosed as NAFLD.Results Twenty four cases in each group were completed with treatment and followed up.There were no significant differences in liver fat accumulation between two groups(P0.05);however,after treatment the TC,BMI,FPG,HbA1c and TG levels in group A were significantly lower than those in group B.Conclusion Metformin can improve glycometabolism in T2DM patients with NAFLD.

About this research paper

What this paper is about

Objective To investigate the change of liver fat contents in type 2 diabetic patients with non-alcoholic fatty liver disease(NAFLD) under metformin treatment.Methods Fifty patients with type 2 diabetes mellitus(T2DM) and NAFLD were assigned to receive metformin treatment(groupA,n=25) or non-metformin treatment(group B,n=25).The intrahepatic fat contents were examined by MRS;the mass of fat peak/the mass of fat peak + the mass of water peak 5.5% was diagnosed as NAFLD.Results Twenty four cases in each group were completed with treatment and followed up.There were no significant differences in liver fat accumulation between two groups(P0.05);however,after treatment the TC,BMI,FPG,HbA1c and TG levels in group A were significantly lower than those in group B.Conclusion Metformin can improve glycometabolism in T2DM patients with NAFLD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the change of liver fat contents in type 2 diabetic patients with non-alcoholic fatty liver disease(NAFLD) under metformin treatment.Methods Fifty patients with type 2 diabetes mellitus(T2DM) and NAFLD were assigned to receive metformin treatment(groupA,n=25) or non-metformin treatment(group B,n=25).The intrahepatic fat contents were examined by MRS;the mass of fat peak/the mass of fat peak + the mass of water peak 5.5% was diagnosed as NAFLD.Results Twenty four cases in each group were completed with treatment and followed up.There were no significant differences in liver fat accumulation between two groups(P0.05);however,after treatment the TC,BMI,FPG,HbA1c and TG levels in group A were significantly lower than those in group B.Conclusion Metformin can improve glycometabolism in T2DM patients with NAFLD.

Key concepts: Metformin, Nonalcoholic fatty liver disease, Internal medicine, Medicine, Fatty liver, Gastroenterology, Type 2 Diabetes Mellitus, Type 2 diabetes

Related papers

Back to paper searchBrowse research topicsOriginal source
Liver fat contents in type 2 diabetic patients with nonalcoholic fatty liver disease under metformin treatment — Research Paper | ScholarLens